Media
News
Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.
Health Canada approves additional indication for NUBEQA® (darolutamide) for the treatment of metastatic castration-sensitive prostate cancer (mCSPC) in combination with docetaxel
In recognition of Breast Cancer Awareness Month, Bayer in Canada launches new breast cancer screening website for patients
Bayer extends clinical development program for finerenone with Phase II study investigating the initial combination therapy with empagliflozin in patients with chronic kidney disease and type 2 diabetes